John LaMattina

John LaMattina

Directeur/Membre du Conseil chez PURETECH HEALTH PLC

Fortune : 10 M $ au 31/05/2026

76 ans
Health Technology
Consumer Services
Finance

Profil

John L.
LaMattina
is the founder of Alivio Therapeutics, Inc. Dr. LaMattina currently serves as Independent Director at Ligand Pharmaceuticals, Inc. since 2011.
He is an Independent Non-Executive Director at PureTech Health LLC since 2009 and Senior Independent Non-Executive Director at PureTech Health Plc since 2009.
He holds trustee positions at Boston College, Worcester Polytechnic Institute, and the Terri Brodeur Breast Cancer Foundation.
Formerly, Dr. LaMattina was Chairman of Gelesis, Inc. from 2013 to 2019.
He was Director at Neurogen Corp.
from 2008 to 2010, Director at Thermo Electron Corp.
from 2002 to 2006, and Director at Human Genome Sciences, Inc. in 2012.
He served as Independent Director at Immunome, Inc. from 2017 to 2023 and Independent Director at Zafgen, Inc. from 2013 to 2020.
He was Director at Vedanta Biosciences, Inc. from 2012 to 2016, President at Pfizer (St. Louis) from 2001 to 2007, and Senior Vice President-Worldwide Development at Pfizer Inc. from 1999 to 2008.
He also held director roles at Thermo Fisher Scientific, Inc. from 2002 to 2006, and at Decision Options LLC and Ziarco Pharma Ltd. Education includes an undergraduate degree from Boston College in 1971 and a doctorate from the University of New Hampshire in 1975.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
05/06/2026 31 560 ( 0,16 % ) 7 M $ 31/05/2026
10/04/2026 1 382 432 ( 0,57 % ) 3 M $ 31/05/2026

Postes actifs de John LaMattina

SociétésPosteDébut
LIGAND PHARMACEUTICALS INCORPORATED Directeur/Membre du Conseil 01/02/2011
PURETECH HEALTH PLC Directeur/Membre du Conseil 01/01/2009
Fondateur -
Terri Brodeur Breast Cancer Foundation
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/01/2009

Anciens postes connus de John LaMattina

SociétésPosteFin
IMMUNOME, INC. Directeur/Membre du Conseil 02/10/2023
LARIMAR THERAPEUTICS, INC. Directeur/Membre du Conseil 01/04/2020
░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de John LaMattina

Formation de John LaMattina

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

97

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Terri Brodeur Breast Cancer Foundation

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. John LaMattina
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇